Developing Irreversible Inhibitors of the Protein Kinase Cysteinome-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Developing Irreversible Inhibitors of the Protein Kinase Cysteinome

Published:2013-02 Issue:2 Volume:20 Page:146-159
ISSN:1074-5521
Container-title:Chemistry & Biology
language:en
Short-container-title:Chemistry & Biology

Author:

Liu Qingsong,Sabnis Yogesh,Zhao Zheng,Zhang Tinghu,Buhrlage Sara J.,Jones Lyn H.,Gray Nathanael S.

Publisher

Elsevier BV

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Biology,Molecular Medicine,General Medicine,Biochemistry

Reference74 articles.

1. Specific inhibitor of FGF receptor signaling: FGF-2-mediated effects on proliferation, differentiation, and MAPK activation are inhibited by PD173074 in oligodendrocyte-lineage cells;Bansal;J. Neurosci. Res.,2003

2. Irreversible protein kinase inhibitors: balancing the benefits and risks;Barf;J. Med. Chem.,2012

3. In vivo efficacy of natural product-inspired irreversible kinase inhibitors;Barluenga;ChemBioChem,2010

4. Binding of manumycin A inhibits IkappaB kinase beta activity;Bernier;J. Biol. Chem.,2006

5. PFAAT version 2.0: a tool for editing, annotating, and analyzing multiple sequence alignments;Caffrey;BMC Bioinformatics,2007

Cited by 585 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Conserved gatekeeper methionine regulates the binding and access of kinase inhibitors to ATP sites of MAP2K1, 4, and 7: Clues for developing selective inhibitors;Bioorganic & Medicinal Chemistry Letters;2024-11

2. Design, synthesis and activity screening of cedrol derivatives as small molecule JAK3 inhibitors;Bioorganic Chemistry;2024-11

3. Structure‐Guided Drug Design Targeting Abl Kinase: How Structure and Regulation Can Assist in Designing New Drugs;ChemBioChem;2024-09-12

4. Design, synthesis and cytotoxic evaluation of new thieno[2,3-d]pyrimidine analogues as VEGFR-2/AKT dual inhibitors, apoptosis and autophagy inducers;Bioorganic Chemistry;2024-09

5. Recent developments in receptor tyrosine kinase inhibitors: A promising mainstay in targeted cancer therapy;Medicine in Drug Discovery;2024-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3